| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.069 | 0.07 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.071 | 0.07 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.07 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | 0.067 | 0.07 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.1 | 0.07 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.059 | 0.07 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.11 | 0.07 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.062 | 0.07 |
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | 0.088 | 0.08 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.07 | 0.08 |